EP2847084B1 - Closure cap - Google Patents
Closure cap Download PDFInfo
- Publication number
- EP2847084B1 EP2847084B1 EP13722394.7A EP13722394A EP2847084B1 EP 2847084 B1 EP2847084 B1 EP 2847084B1 EP 13722394 A EP13722394 A EP 13722394A EP 2847084 B1 EP2847084 B1 EP 2847084B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- cap
- closure cap
- container
- stoppers
- infusion solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Not-in-force
Links
- 239000003978 infusion fluid Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 17
- 238000007789 sealing Methods 0.000 claims description 16
- 229920001971 elastomer Polymers 0.000 claims 1
- 239000000806 elastomer Substances 0.000 claims 1
- 229920002725 thermoplastic elastomer Polymers 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000007799 cork Substances 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 235000015040 sparkling wine Nutrition 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D41/00—Caps, e.g. crown caps or crown seals, i.e. members having parts arranged for engagement with the external periphery of a neck or wall defining a pouring opening or discharge aperture; Protective cap-like covers for closure members, e.g. decorative covers of metal foil or paper
- B65D41/02—Caps or cap-like covers without lines of weakness, tearing strips, tags, or like opening or removal devices
- B65D41/28—Caps combined with stoppers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
- A61J1/1487—Inlet or outlet ports with friction fit, e.g. connecting tubes directly to a protruding port
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D39/00—Closures arranged within necks or pouring openings or in discharge apertures, e.g. stoppers
- B65D39/04—Cup-shaped plugs or like hollow flanged members
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1431—Permanent type, e.g. welded or glued
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/042—Force radial
- F04C2270/0421—Controlled or regulated
Definitions
- the invention relates to a cap with a flange for connection to a flange of an infusion solution container, wherein the cap has at least one integrated stopper for the removal or introduction of liquids from or into the container and for resealing after the removal or the introduction of liquid.
- a freeze-drying stopper made of rubber-elastic material, consisting of a pin and an associated one-piece circular-shaped flange.
- the pin includes a cavity surrounding the pin longitudinal axis which is open to the free pin end face and extends to a central closed wall portion of the flange.
- a first portion of the pin located between a first transverse plane defined by the lower boundary surface of the flange and a second plane has a closed outer peripheral surface having a maximum diameter.
- a subsequent second section includes a passage communicating with the cavity, as well as a plurality of protruding barriers.
- DE 10 2008 060 457 A1 describes a method of manufacturing a closure.
- a method for producing a closure (1) for a sterile medicament container it is provided that in an inelastic closure body (2) having at least one puncture opening (11), an elastic sealing element (3) is used, which at least one Closing opening (11) sealing.
- the sealing element (3) is materially connected to the closure body (2), in which on the sealing element (3) and the closure body (2) mating areas (12,13) are melted prior to insertion, wherein the fused areas (12, 13) upon insertion of the sealing element (3) are brought into contact with each other, cool and connect.
- DE-PS 25 04 253 describes a container for storing and dispensing sterile solutions.
- this container comprises a tightly closed inlet device with a laterally projecting at the end of a neck integrally formed with the neck wall, the opening of the neck before enclosing flange, wherein further in a space enclosed by a side wall of the inlet device space at least one passage is arranged and the Side wall at one end surrounding lateral projecting flange covers the flange provided on the neck and is tightly connected thereto.
- EP 1 211 184 A1 Fig.15, describes a cap with a disc-shaped flange according to the preamble of claim 1.
- DE 103 40 538 A1 describes a sample container for holding liquids for medical analysis.
- a sealing plug 3 which extends into the open end of the tube with a cylindrical sealing section and seals the tube there with respect to the inner wall 13, is inserted in perfect register with the closure of the tube 2 so that the cylindrical sealing section 9 does not undersize the bottle mouth. but rather has an excess of the bottle mouth, so that it can not dip into this without effort.
- the problem with the closure caps described in the prior art is the permanent connection of these with the bottle mouth of the infusion solution container.
- the state of the art makes its own to press the plug into the mouth of the bottle, as is customary, for example, in the closure of sparkling wine corks.
- the flange of the Sparkling wine cork limits the immersion depth of the cork into the bottle. In this case, however, a removal or introduction of liquid from or into the container or a re-seal after the removal or the introduction of liquid into the container is not possible without completely removing the cork.
- the object of the present invention is further to reduce the dead volume in the area of the bottle mouth of an infusion solution container.
- the present object is achieved by a closure cap and an associated infusion solution container according to claim 1.
- the present invention is in particular a closure or access cap 1 for the removal of solutions, in particular outside of rigid container systems.
- the cap 1 is placed on the rim or flange provided on the container and connected here cohesively or non-positively with the infusion solution container.
- the construction of the cap 1 according to the invention is particularly tailored to open containers, generally made by extrusion blown (EBM) or injection stretch blown (ISBM).
- EBM extrusion blown
- ISBM injection stretch blown
- the geometry of the flanges corresponds to the degree of ovality of the Flanschkorpuses and can be carried out accordingly circular or elliptical.
- the entire system consists structurally of the actual cap body 1 with the connecting flange 2, the inserted plug 3 for injecting or withdrawing solutions with resealing, their designed as receiving areas for infusion solution channels 5a, 5b and in particular a sealing film 10 with originality.
- the latter can, depending on the design, in principle be sealed over the whole area on the cap 1 or only partially in the region of the stopper 3.
- a separating membrane is preferably injected radially inwards. This can be integrally connected to the cap body 1 depending on the design or consist of two parts, which are connected to one another in a material-locking manner, for example, in a separate joining process.
- connection of the plug 3 with the cap body 1 can be done in principle by joining, for example, laser welding, Verbörderln the receiving cups or clamps with holding a separate part.
- the sealing of the cover sheet 10 takes place - as the name implies - via a sealing process, which represents the appropriate technology for films of this type. It thus corresponds to commercially available caps 1, depending on the type of components used.
- the container systems for infusion solutions available on the market contain a greater or lesser amount of air above the solution level. This allows for a uniform flow or withdrawal rate, depending on the flexibility of the container, and also controls the residual volume remaining in the container after infusion.
- the so-called headspace but also the penetration depth of the infusion spike or that is located around the spike, not responsible for the spike opening volumes. This is where the essence of the present invention begins.
- the plug 3 or the septum is laid inwards into the bottle mouth.
- the open mouth region, in particular ISBM-produced container allows such a construction.
- the cap body 1 which points into the mouth area of the bottle fills the bottleneck volume almost completely and drastically reduces the residual volume in the container after removal. Because the cap body 1 located in the mouth region bridges the liquid volume not detected by the spike, the residual volume can be drastically reduced to values of, for example, less than 2 ml.
- channels 5a, 5b are made possible in particular by communicating channels 5a, 5b between the two puncture openings and further channels which extend in the direction of the circumference of the body of the cap 1.
- the channels 5a, 5b become tubes to be communicated and thereby allow, also the emptying of the unused puncture site, in the event that more than one stopper is provided.
- the cap 1 according to the invention is suitable with a particular circular disc-shaped flange 2 for connection to a likewise in particular circular disc-shaped flange 2 of an infusion solution container.
- the connection of the two flanges 2 can be done either by external heat input, such as infrared welding or internal heat generation by ultrasound, vertical or oscillating. In addition to welding, gluing, pressing or clipping is also possible.
- An encapsulation of the components is also a way the Closure cap 1 according to the invention to be connected to the infusion solution container.
- the cap 1 or displacer 4 it is important for the purposes of the present invention that it has an undersize, but does not seal the bottleneck. While an interference fit is produced in the prior art, according to the invention a gap remains between the displacement body 4 and the neck of the bottle which fills with liquid in use and also forms an optionally colored capillary gap depending on the coloring of the liquid. Undersize in the sense of the present invention means that the displacement body 4 can slide without force, similar to a piston in a cylinder of an internal combustion engine, here the neck of the bottle.
- the plugs 3 may be formed as a septum, which are microbiologically sealingly connected to the cap 1 according to known methods.
- the closure cap 1 according to the invention can also have further webs 9 in the region of the disk-shaped flange 2. These extend over a planar annular boundary surface of the flange 2 in a length which allows a positive, cohesive or non-positive connection of this flange 2 with a flange 2 of the infusion solution container.
- the preferably annular bearing surface of the Flange 2 has a larger radius than the also annular boundary surface, which is covered by grooves.
- additional injection volumes can be added for the injection region in addition to the container solution with a conventional hypodermic needle.
- the withdrawal port may be pierced with a commercial spike for administration of the solution as in the prior art.
- the removal of the solution can also be done via a needle-free access, which eliminates the use of a needle.
- a cap according to the invention 1 is shown with a circular disc-shaped flange 2, which (not shown) for connection to a likewise circular disc-shaped flange 2 of an infusion solution container.
- the cap 1 herein comprises two integral plugs 3a, 3b for withdrawing or introducing liquid from or into the container, and for resealing after removal or introduction of liquid.
- the plugs 3a, 3b are preferably made of elastic material, in particular of a thermoplastic material, and connected in a conventional manner to the body microbiologically sealing.
- the cap 1 according to the invention also has a body 4 directed inwards, in the direction of the bottle mouth, which is designed in the form of a displacement body 4.
- a displacement body 4 With the help of this displacement body 4, the dead volume of the container is reduced overall.
- the displacement body 4 opposite the bottle mouth (not shown) on an undersize, so that this displacement body 4 can dive without effort in this bottle mouth.
- the sealing film 10 which covers the two plugs 3a, 3b here. Further recognizable are the channels 5a, 5b, with the communicating passages / cuts 6a, 6b, 6c, 6d. These allow the fluid exchange between the channels 5a, 5b, especially if they extend only over part of the length of the body 4.
- the passages / cuts of the channels are in the Fig. 2 once again clearly highlighted.
- the communicating channels 5a, 5b thus allow the residual volume from the injection area to flow into the removal area for removal there.
- passages / cuts 7 a, 7 b, 7 c, 7 d are present, which allow a complete flushing all areas of the bottle mouth.
- Fig. 3 In the Fig. 3 is shown that the radial surface of the displacement body 4 of the closure cap 1 in the region of the bottle mouth webs 8, which extend from the flange 2 in the direction of the infusion solution container.
- These webs 8 allow a complete flushing of this area between the cap 1 and the bottle mouth of the infusion solution container, which is extremely important for a later sterilization.
- This guarantee of sterilization of this area can also be promoted, inter alia, that also has a planar annular boundary surface of the flange 2 also webs 9, which allows complete flushing of the flange of the bottle neck in this area. In this way it can be ensured that even after the connection of the cap 1 with the infusion solution container, all areas in contact with the liquid can be sterilized.
- the present invention further comprises a corresponding infusion solution container with the above-defined cap 1, which are welded together, glued, pressed or clipped together.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Closures For Containers (AREA)
Description
Gegenstand der Erfindung ist eine Verschlusskappe mit einem Flansch zur Verbindung mit einem Flansch eines Infusionslösungsbehälters, wobei die Kappe wenigstens einen integrierten Stopfen zur Entnahme oder zur Einbringung von Flüssigkeiten aus dem oder in den Behälter und zur Wiederabdichtung nach der Entnahme oder der Einbringung von Flüssigkeit aufweist.The invention relates to a cap with a flange for connection to a flange of an infusion solution container, wherein the cap has at least one integrated stopper for the removal or introduction of liquids from or into the container and for resealing after the removal or the introduction of liquid.
Problematisch bei den im Stand der Technik beschriebenen Verschlusskappen ist die dauerhafte Verbindung dieser mit der Flaschenmündung des Infusionslösungsbehälters. Hier macht sich der Stand der Technik zu eigen, den Stopfen in die Flaschenmündung hineinzupressen, wie dies beispielsweise beim Verschluss von Schaumweinkorken üblich ist. Der Flansch des Schaumweinkorkens begrenzt dabei die Eintauchtiefe des Korkens in die Flasche. Hierbei ist jedoch eine Entnahme oder Einbringung von Flüssigkeit aus den oder in den Behälter oder auch eine Wiederabdichtung nach der Entnahme oder der Einbringung von Flüssigkeit in den Behälter nicht möglich, ohne den Korken vollständig zu entfernen.The problem with the closure caps described in the prior art is the permanent connection of these with the bottle mouth of the infusion solution container. Here, the state of the art makes its own to press the plug into the mouth of the bottle, as is customary, for example, in the closure of sparkling wine corks. The flange of the Sparkling wine cork limits the immersion depth of the cork into the bottle. In this case, however, a removal or introduction of liquid from or into the container or a re-seal after the removal or the introduction of liquid into the container is not possible without completely removing the cork.
Die Aufgabe der vorliegenden Erfindung besteht weiter darin, das Totvolumen im Bereich der Flaschenmündung eines Infusionslösungsbehälters zu reduzieren.The object of the present invention is further to reduce the dead volume in the area of the bottle mouth of an infusion solution container.
Die vorliegende Aufgabe wird gelöst durch eine Verschlusskappe und einen damit verbundenen Infusionlösungsbehälter gemäß Anspruch 1. Bei der vorliegenden Erfindung handelt es sich insbesondere um eine Verschluss- oder Zugangskappe 1 zur Entnahme von Lösungen, insbesondere außerhalb starrer Behältersystemen. Die Kappe 1 wird auf den am Behälter vorgesehenen Rand oder Flansch aufgesetzt und hier stoffschlüssig oder kraftschlüssig mit dem Infusionslösungsbehälter verbunden. Die Konstruktion der erfindungsgemäßen Kappe 1 ist insbesondere auf offene Behälter zugeschnitten, die im Allgemeinen im Extrusionsblasverfahren (EBM) oder Spritz-Streckblasverfahren (ISBM) hergestellt werden. Vorzugsweise entspricht die Geometrie der Flansche dem Ovalitätsgrad des Flanschkorpuses und kann dementsprechend kreisrund oder elliptisch ausgeführt sein.The present object is achieved by a closure cap and an associated infusion solution container according to
Das Gesamtsystem besteht konstruktiv aus dem eigentlichen Kappenkörper 1 mit dem Verbindungsflansch 2, den eingelegten Stopfen 3 zum Zuspritzen oder Entnehmen von Lösungen mit Wiederabdichtung, deren als Aufnahmebereiche für Infusionslösung ausgeführten Kanäle 5a, 5b sowie insbesondere einer Siegelfolie 10 mit Originalitätsnachweis. Letztere kann abhängig von der Bauart prinzipiell ganzflächig auf die Kappe 1 aufgesiegelt werden oder auch nur partiell im Bereich der Stopfen 3.The entire system consists structurally of the
Um der erfinderischen Kappe 1 Verdrängungseigenschaften für das Flaschenhalsvolumen zu geben, ist vorzugsweise innen radial eine Trennmembran angespritzt. Diese kann abhängig von der Ausführung einteilig mit dem Kappenkörper 1 verbunden sein oder aus zwei Teilen bestehen, die beispielsweise in einem separaten Fügeprozess stoffschlüssig miteinander verbunden werden.In order to give the
Die Verbindung der Stopfen 3 mit dem Kappenkörper 1 kann prinzipiell durch Fügen, beispielsweise Laserschweißen, Verbörderln der Aufnahmenäpfe oder Klemmen mit Gegenhalten eines separaten Teils erfolgen. Das Aufsiegeln der Deckfolie 10 erfolgt - wie der Name schon sagt - über einen Siegelprozess, der für Folien dieser Art die geeignete Technologie darstellt. Sie entspricht damit von der Art der verwendeten Komponenten her handelsüblichen Kappen 1.The connection of the plug 3 with the
Die am Markt befindlichen Behältersysteme für Infusionslösungen enthalten eine mehr oder weniger große Menge an Luft oberhalb des Lösungsspiegels. Diese ermöglicht abhängig von der Flexibilität des Behälters eine gleichmäßige Fluss- oder Entnahmerate und reguliert auch das nach der Infusion im Behälter verbleibende Restvolumen. Neben dem erwähnter Behälterluftvolumen, dem sogenannten Headspace, ist aber auch die Eindringtiefe des Infusionsspikes bzw. das um den Spike herum befindliche, nicht der Spikeöffnung erfassbare Volumen verantwortlich. Hier setzt der Kern der vorliegenden Erfindung an.The container systems for infusion solutions available on the market contain a greater or lesser amount of air above the solution level. This allows for a uniform flow or withdrawal rate, depending on the flexibility of the container, and also controls the residual volume remaining in the container after infusion. In addition to the mentioned container air volume, the so-called headspace, but also the penetration depth of the infusion spike or that is located around the spike, not responsible for the spike opening volumes. This is where the essence of the present invention begins.
Während die üblichen, am Markt befindlichen Kappensysteme für halbstarre Infusionslösungsbehälter einen nach außen gestellten Entnahmebereich aufweisen, der in seiner Gestaltung auf die Dimensionen der Kopfmembran der BFS-Container zugeschnitten ist, wird erfindungsgemäß der Stopfen 3, beziehungsweise das Septum nach innen in die Flaschenmündung verlegt. Der offene Mündungsbereich, insbesondere ISBM-hergestellte Behälter erlaubt eine derartige Bauweise. Der in den Mündungsbereich der Flasche zeigende Kappenkörper 1 füllt das Flaschenhalsvolumen nahezu vollständig aus und reduziert das Restvolumen im Behälter nach der Entnahme drastisch. Dadurch, dass der im Mündungsbereich liegende Kappenkörper 1 das vom Spike nicht erfasste Flüssigkeitsvolumen überbrückt, kann das Restvolumen drastisch auf Werte von beispielsweise unterhalb 2 ml verringert werden.While the usual capsule systems on the market for semi-rigid infusion solution containers have an outward removal region whose design is tailored to the dimensions of the head membrane of the BFS containers, according to the invention the plug 3 or the septum is laid inwards into the bottle mouth. The open mouth region, in particular ISBM-produced container allows such a construction. The
Diese geringen Totvolumina werden insbesondere durch kommunizierende Kanäle 5a, 5b zwischen den beiden Einstichöffnungen sowie weiteren Kanälen ermöglicht, die sich in Richtung des Umfangs des Korpus der Kappe 1 erstrecken. Somit werden die Kanäle 5a, 5b zu kommunizierenden Röhren und erlauben dadurch, auch das Leerlaufen der jeweils nicht benutzten Einstichstelle, für den Fall, dass mehr als ein Stopfen vorgesehen ist.These small dead volumes are made possible in particular by communicating
Die erfindungsgemäße Verschlusskappe 1 ist mit einem insbesondere kreisscheibenförmigen Flansch 2 zur Verbindung mit einem ebenfalls insbesondere kreisscheibenförmigen Flansch 2 eines Infusionslösungsbehälters geeignet. Die Verbindung der beiden Flansche 2 kann entweder über externen Wärmeeintrag, beispielsweise Infrarotschweißen oder interne Wärmeerzeugung per Ultraschall, vertikal oder oszillierend erfolgen. Auch ist neben dem Verschweißen das Verkleben, Verpressen oder Verklipsen möglich. Eine Umspritzung der Komponenten ist ebenfalls eine Möglichkeit die erfindungsgemäße Verschlusskappe 1 mit dem Infusionslösungsbehälter zu verbinden.The
In Bezug auf die dimensionale Ausführung des Kappen- 1 oder Verdrängerkörpers 4 ist es im Sinne der vorliegenden Erfindung von Bedeutung, dass dieser ein Untermaß aufweist, jedoch nicht abdichtend zum Flaschenhals erfolgt. Während im Stand der Technik ein Presssitz erzeugt wird, bleibt erfindungsgemäß zwischen dem Verdrängungskörper 4 und dem Flaschenhals ein Spalt, der sich bei Gebrauch mit Flüssigkeit füllt und abhängig von der Einfärbung der Flüssigkeit auch einen gegebenenfalls farbigen Kapillarspalt bildet. Untermaß im Sinne der vorliegenden Erfindung bedeutet, dass der Verdrängungskörper 4 ähnlich einem Kolben in einem Zylinder eines Verbrennungsmotors, hier des Flaschenhalses, ohne Kraftaufwand gleiten kann.With regard to the dimensional design of the
Am Verdrängerkörper 4 angebrachte Stege 8 im Bereich und entlang der zylindrischen Mantelfläche erlauben gezielt den Zugang der Flüssigkeit in diesen Bereich. Diese zunächst nachteilig erscheinende Eigenschaft der nicht abdichtenden Gestaltung macht die Validierung des Sterilisationsprozesses aber deutlich einfacher, da der Ringspalt den Zutritt der Behälterflüssigkeit in alle Bereiche des Flaschenhalses erlaubt und so als Indikator für eine erfolgte Autoklavierung auch eine Sterilisierung der Flaschenmündung erlaubt.On the displacer 4 mounted
Wie im Stand der Technik üblich, können die Stopfen 3 als Septum ausgebildet sein, die nach an sich bekannten Verfahren mikrobiologisch abdichtend mit der Kappe 1 verbunden sind. Neben den Stegen 8 des Verdrängerkörpers 4 kann die erfindungsgemäße Verschlusskappe 1 auch weitere Stege 9 im Bereich des scheibenförmigen Flanschs 2 aufweisen. Diese erstrecken sich über eine plane ringförmige Begrenzungsfläche des Flansches 2 in einer Länge, die eine formschlüssige, stoffschlüssige oder kraftschlüssige Verbindung dieses Flansches 2 mit einem Flansch 2 des Infusionslösungsbehälters ermöglicht. Dementsprechend weist die vorzugsweise kreisringförmige Auflagefläche des Flansches 2 einen größeren Radius auf, als die ebenfalls kreisringförmige Begrenzungsfläche, die durch Rillen umfasst ist.As is usual in the prior art, the plugs 3 may be formed as a septum, which are microbiologically sealingly connected to the
Durch die, sich im Bereich der Kappe 1 befindlichen Stopfen 3 kann für den Zuspritzbereich zusätzlich zur Behälterlösung mit einer üblichen hypodermischen Nadel auch weiteres Zuspritzvolumina zugegeben werden. Der Entnahmeport kann zur Verabreichung der Lösung, wie im Stand der Technik auch, mit einem handelsüblichen Spike durchstochen werden. Je nach Anwendungsfall und Bauform kann die Entnahme der Lösung auch über einen Needle-free-Zugang erfolgen, was die Benutzung einer Nadel eliminiert.By means of the plug 3 located in the region of the
In der
Die erfindungsgemäße Kappe 1 weist weiterhin einen nach innen, in Richtung der Flaschenmündung gerichteten Korpus 4 auf, der in Form eines Verdrängerkörpers 4 ausgebildet ist. Mit Hilfe dieses Verdrängerkörpers 4 wird das Totvolumen des Behälters insgesamt reduziert. Entgegen dem Stand der Technik weist der Verdrängerkörper 4 gegenüber der Flaschenmündung (nicht dargestellt) ein Untermaß auf, so dass dieser Verdrängerkörper 4 ohne Kraftaufwand in diese Flaschenmündung eintauchen kann.The
In der
Die Durchlässe/Einschnitte der Kanäle werden in der
In der
Die vorliegende Erfindung umfasst weiterhin einen entsprechenden Infusionslösungsbehälter mit der oben definierten Kappe 1, wobei diese miteinander verschweißt, verklebt, verpresst oder verclipst sind.The present invention further comprises a corresponding infusion solution container with the above-defined
Claims (9)
- A closure cap (1) with a disk-shaped flange (2), which is connected with a disk-shaped flange of an infusion solution container, wherein the cap (1) has at least one integrated stopper (3a, 3b) for withdrawing or supplying liquid from, or into, the container and for resealing after the withdrawal or supply of liquid,
wherein
the cap (1) has a body (4) in the form of a displacer (4) directed inwardly in the direction of the bottle mouth of the infusion solution container, which reduces the dead volume of the container, the closure cap has two stoppers (3a, 3b), which are individually and independently accessible, said stoppers (3a, 3b) are respectively allocated to communicating channels (5a, 5b) in the area of the body (4), characterized in that said cap (1) is capable of being inserted into the bottle mouth without application of force because of an undersize with respect to the bottle mouth,
said channels (5a, 5b) have one or more passages/notches (6a, 6b, 6c, 6d) in the circumferential area, which extend over part of the length of the body (4), wherein the passages/notches (6a, 6b, 6c, 6d) enable the exchange of liquid between the channels (5a, 5b), or together with passages/notches (7a, 7b, 7c, 7d) arranged in the outer circumference of said displacer (4), allow the liquid to flow throughout the areas of the bottle mouth,
said cap (1) has ridges (9) in the area of a planar annular boundary surface of the flange (2), and
said stoppers (3a, 3b) include an elastomer. - The closure cap (1) according to claim 1, characterized in that said displacer (4) has a one-piece or multi-piece design.
- The closure cap (1) according to claim 1, characterized in that the surface of the displacer (4) has ridges (8) near the bottle mouth.
- The closure cap (1) according to claim 1, characterized in that said stoppers (3a, 3b) include, especially are made of, a thermoplastic elastomer.
- The closure cap (1) according to claim 1, characterized in that the stoppers (3a, 3b) are designed as septa that are connected with the cap (1) in a microbiologically sealing way.
- The closure cap (1) according to claim 1, characterized by having at least one removable sealing sheet (10), which covers the stopper or stoppers (3a, 3b).
- The closure cap (1) according to any of claims 1 to 4, characterized by being connected by a positive-locking, firmly bonding or friction-type connection with said infusion solution container in the area of the flange (2).
- The closure cap (1) according to claim 7, characterized by being welded, adhesive-bonded, press-bonded or clipped to said infusion solution container.
- An infusion solution container and the closure cap (1) according to any of claims 1 to 8, wherein said cap (1) is welded, adhesive-bonded, press-bonded or clipped to said container.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13722394.7A EP2847084B1 (en) | 2012-05-09 | 2013-05-08 | Closure cap |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20120167271 EP2662303A1 (en) | 2012-05-09 | 2012-05-09 | Closure cap |
PCT/EP2013/059621 WO2013167672A1 (en) | 2012-05-09 | 2013-05-08 | Closure cap |
EP13722394.7A EP2847084B1 (en) | 2012-05-09 | 2013-05-08 | Closure cap |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2847084A1 EP2847084A1 (en) | 2015-03-18 |
EP2847084B1 true EP2847084B1 (en) | 2017-07-12 |
Family
ID=48430753
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20120167271 Withdrawn EP2662303A1 (en) | 2012-05-09 | 2012-05-09 | Closure cap |
EP13722394.7A Not-in-force EP2847084B1 (en) | 2012-05-09 | 2013-05-08 | Closure cap |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20120167271 Withdrawn EP2662303A1 (en) | 2012-05-09 | 2012-05-09 | Closure cap |
Country Status (4)
Country | Link |
---|---|
US (1) | US9731872B2 (en) |
EP (2) | EP2662303A1 (en) |
CN (1) | CN104379463B (en) |
WO (1) | WO2013167672A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWD190916S (en) * | 2016-10-10 | 2018-06-11 | B 布朗梅爾松根股份公司 | Cap system intended for pharmaceutical containers |
CN112618359B (en) * | 2020-11-25 | 2022-06-07 | 安徽华能医用橡胶制品股份有限公司 | Rubber plug for transfusion |
EP4082599A1 (en) * | 2021-04-30 | 2022-11-02 | B. Braun Melsungen AG | Cap for a fluid container, fluid container comprising such cap and method for manufacturing such cap |
CN115107285B (en) * | 2022-06-16 | 2024-04-02 | 乾德生物医疗技术(重庆)有限公司 | Method for manufacturing blood purification device |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3744174A1 (en) * | 1987-12-24 | 1989-07-06 | Helvoet Pharma | FREEZE DRYING PLUG |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3164279A (en) * | 1965-01-05 | Test tube closure | ||
US1871907A (en) * | 1931-04-30 | 1932-08-16 | Crown Cork & Seal Co | Metal cap for closing paper containers |
US2649090A (en) * | 1950-09-29 | 1953-08-18 | American Cyanamid Co | Rubber closure for pharmaceutical vials |
US3059798A (en) * | 1960-02-25 | 1962-10-23 | King Seeley Thermos Co | Stopper for vacuum bottle assembly or the like |
BE794248A (en) * | 1972-02-22 | 1973-05-16 | Baxter Laboratories Inc | IMPROVEMENTS TO STERILE CLOSURES FOR SOLUTION BOTTLES OR VIALS |
US3905368A (en) | 1974-02-15 | 1975-09-16 | Cutter Lab | Pierceable access port assembly |
DE3310265A1 (en) * | 1983-03-22 | 1984-09-27 | Gerhard 7166 Sulzbach-Laufen Hansen | ZIPPER FOR A CONTAINER |
US5320237A (en) * | 1992-07-13 | 1994-06-14 | Stolzman Michael L | Sealed closure for drum |
US5385253A (en) * | 1992-09-02 | 1995-01-31 | Baxter International Inc. | Port closure |
DE4428434A1 (en) * | 1994-08-11 | 1996-02-15 | Boehringer Ingelheim Kg | Sealing cap and method for filling gas-free containers |
DE19500460A1 (en) * | 1995-01-10 | 1996-07-11 | Pohl Gmbh & Co Kg | Arrangement on infusion bottles or the like |
DE19615422A1 (en) * | 1996-04-19 | 1997-11-20 | Boehringer Ingelheim Kg | Two-chamber cartridge for propellant-free MDIs |
DE60043734D1 (en) | 1999-04-20 | 2010-03-11 | Jms Co Ltd | CONTAINER CAP FOR TANK AND LIQUID TRANSFER DEVICE |
US6716396B1 (en) * | 1999-05-14 | 2004-04-06 | Gen-Probe Incorporated | Penetrable cap |
DE10127823C1 (en) * | 2001-06-07 | 2002-08-22 | West Pharm Serv Drug Res Ltd | Closure for a medication bottle and process for its manufacture |
US8303914B2 (en) * | 2003-01-06 | 2012-11-06 | Becton, Dickinson And Company | Tube closure with removable septum for direct instrument access |
CN2626482Y (en) * | 2003-06-20 | 2004-07-21 | 田壮禾 | Compound plastic seal lid for medical use |
DE10340538B4 (en) * | 2003-09-03 | 2005-07-07 | Kabe-Labortechnik Gmbh | Tube to hold fluid samples for medical analysis, in an automated system where a needle extracts the sample, has a stopper with an outer cylindrical seal and an inner rubber insert for protection against contamination and infection |
CN2642706Y (en) * | 2003-09-16 | 2004-09-22 | 湖南千山制药机械股份有限公司 | Lug boss type composite cover with bicylinder inner plug for big transfusion soft bag and bottle |
DE102004051300C5 (en) * | 2004-10-20 | 2013-01-24 | Fresenius Kabi Deutschland Gmbh | Cap for containers filled with medical fluids |
CN2822625Y (en) * | 2005-10-18 | 2006-10-04 | 喻敏 | Sealing cover of transfusion container |
CL2007002373A1 (en) * | 2006-08-17 | 2008-01-11 | Zork Pty Ltd | A bottle closure for bottles containing high-pressure liquids, with the closure having a first part and a second part, where the first part has a portion adapted to receive a portion of an upper section of a bottleneck, and a second part that fits over the first part. |
US8091727B2 (en) * | 2007-11-08 | 2012-01-10 | Hospira, Inc. | Snap-over clamshell protective port cap |
DE102008060864A1 (en) * | 2008-12-09 | 2010-06-10 | Fresenius Kabi Deutschland Gmbh | Cap for containers for holding medical fluids and container for holding medical fluids |
DE102008060457A1 (en) | 2008-12-09 | 2010-06-10 | West Pharmaceutical Services Deutschland Gmbh & Co. Kg | Closure manufacturing method for sterile medicament container, involves introducing sealing element into closure body, bringing annular- and grid shaped regions in contact with each other, cooling and connecting regions |
EP2759284A1 (en) * | 2013-01-28 | 2014-07-30 | B. Braun Melsungen AG | Overcap intended for a pharmaceutical container |
-
2012
- 2012-05-09 EP EP20120167271 patent/EP2662303A1/en not_active Withdrawn
-
2013
- 2013-05-08 CN CN201380020307.1A patent/CN104379463B/en not_active Expired - Fee Related
- 2013-05-08 US US14/394,671 patent/US9731872B2/en active Active
- 2013-05-08 EP EP13722394.7A patent/EP2847084B1/en not_active Not-in-force
- 2013-05-08 WO PCT/EP2013/059621 patent/WO2013167672A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3744174A1 (en) * | 1987-12-24 | 1989-07-06 | Helvoet Pharma | FREEZE DRYING PLUG |
Also Published As
Publication number | Publication date |
---|---|
WO2013167672A1 (en) | 2013-11-14 |
EP2847084A1 (en) | 2015-03-18 |
CN104379463A (en) | 2015-02-25 |
US9731872B2 (en) | 2017-08-15 |
US20150069008A1 (en) | 2015-03-12 |
EP2662303A1 (en) | 2013-11-13 |
CN104379463B (en) | 2016-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1498600C2 (en) | Self-sealing, pierceable plug made of elastomeric material | |
DE102004051300B3 (en) | Cap for containers filled with medical fluids | |
EP2667838B1 (en) | Connecting device for connecting a first reservoir to a second reservoir | |
DE60019446T2 (en) | LIQUID TRANSFER SET FOR PHYOLS AND OTHER MEDICAL CONTAINERS | |
EP2651471B1 (en) | Device for withdrawing liquid from a container | |
DE602004007962T2 (en) | LIQUID CONNECTION FOR A BLOOD COLLECTION DEVICE | |
EP2376341B1 (en) | Closure for a container for pharmaceuticals | |
DE10247963A1 (en) | Pre-filled syringe with membrane seal, has cylinder, connector and sealing membrane constructed in one piece as plastic injection-molded part | |
EP3274266B1 (en) | Sealing cap for a container for holding a medical liquid | |
DE102008048988A1 (en) | Device for connecting a syringe to a container or a hose line | |
EP0788804A2 (en) | Medical applicator | |
EP2847084B1 (en) | Closure cap | |
AT505616A4 (en) | INJECTION sYRINGE | |
DE102007024539A1 (en) | Cap for a container for holding liquids, in particular an enteral nutrient solution and container with such a cap | |
DE60200078T2 (en) | infusion container | |
DE102013012809A1 (en) | Head piece for a container that can be filled with a medium | |
DE69218727T2 (en) | Medicine container | |
WO2015154115A2 (en) | Receiver container and receiver unit for receiving body fluid | |
DE20215807U1 (en) | syringe barrel | |
WO2016015742A1 (en) | Container having a head piece, which container can be or is filled with a medium | |
EP3618962B1 (en) | Collection assembly or test tube for a small amount of a body fluid, comprising an extender element | |
EP2753289B1 (en) | Liquid container with predetermined break point | |
DE3716586C2 (en) | Plastic container for storing and applying a catheter lubricant and process for its production | |
DE102017119225B4 (en) | Device for storing, conveying or dosing nutritional solutions, liquid medicaments or the like, as well as a method for producing such a device | |
DE102009019503A1 (en) | Device for the removal of medical fluids from disposable packaging, such as infusion or transfusion bags or bottles, has hollow connecting part which has packing-side outlet and connection-side receptacle with pierceable membrane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20141017 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BEINE, JOACHIM |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20160615 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20170123 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 908097 Country of ref document: AT Kind code of ref document: T Effective date: 20170715 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502013007745 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20170712 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171012 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171112 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171013 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171012 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502013007745 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 |
|
26N | No opposition filed |
Effective date: 20180413 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20180531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180531 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180531 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 908097 Country of ref document: AT Kind code of ref document: T Effective date: 20180508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20130508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170712 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170712 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20220523 Year of fee payment: 10 Ref country code: FR Payment date: 20220523 Year of fee payment: 10 Ref country code: DE Payment date: 20220519 Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 502013007745 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20230508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231201 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230531 |